| (Values in U.S. Thousands) | Dec, 2021 | Dec, 2020 | Mar, 2026 | Mar, 2026 | Mar, 2026 |
| Sales | 11,040 | 6,580 | 0 | 0 | 0 |
| Sales Growth | +67.78% | unch | unch | unch | unch |
| Net Income | -38,960 | -18,010 | 0 | 0 | 0 |
| Net Income Growth | -116.32% | unch | unch | unch | unch |
Codex Dna Inc (DNAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Codex DNA Inc. is a creator of the BioXp(TM) system, a fully automated benchtop instrument which enables numerous synthetic biology workflows. Codex DNA Inc. is based in SAN DIEGO.